Related Experiment Video
Updated: Aug 8, 2026

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
Published on: October 12, 2014
Role of apoptosis in cardiac allograft vasculopathy
1Institute of Immunology, University of Kiel, Brunswiker Str. 4, 24104 Kiel, Germany. kabelitz@immunologie.uni-kiel.de
Insights
Cardiac allograft vasculopathy (CAV), a complication of heart transplants, may involve programmed cell death (apoptosis) of endothelial cells. Preventing apoptosis could be a future therapy for CAV.
Area of Science:
- Cardiovascular Science
- Transplantation Immunology
- Cell Biology
Background:
- Cardiac allograft vasculopathy (CAV) is a significant long-term issue following heart transplantation.
- Endothelial injury in transplanted hearts triggers immune responses, causing inflammation and vascular smooth muscle cell proliferation.
- Emerging evidence points to apoptosis as a key mechanism of endothelial cell death in early transplant arteriopathy.
Purpose of the Study:
- To discuss the potential role of apoptosis in the development of cardiac allograft vasculopathy (CAV).
- To explore the implications of apoptosis in CAV for future therapeutic strategies.
Main Methods:
- Review of recent studies on endothelial cell death in transplant arteriopathy.
- Conceptual discussion on the role of programmed cell death (apoptosis) in CAV pathogenesis.
Main Results:
- Endothelial cell death during early CAV development appears to occur via apoptosis.
- Apoptosis is implicated as a potential driver of vascular changes in CAV.
Conclusions:
- Apoptosis plays a potential role in the initiation and progression of cardiac allograft vasculopathy.
- Targeting and preventing apoptosis during the early stages of CAV may offer a novel therapeutic approach.
Abstract:
Cardiac allograft vasculopathy (CAV) is a major long-term complication of heart transplantation. Coronary endothelial injury provokes immunological reactions leading to inflammation and proliferation of vascular smooth muscle cells. Recent studies suggest that cell death of endothelial cells during early phases of transplant arteriopathy development proceeds via programmed cell death (apoptosis). The potential role of apoptosis in CAV is discussed. Based on these concepts, therapeutic strategies might be envisaged aimed at the prevention of apoptosis during the initiating phase of CAV.
Related Concept Videos
Apoptosis
Cardiomyopathy V: Interprofessional Care

